Jessica Ruzzolini Selected Research

Jessica Ruzzolini Research Topics

Disease

18	Neoplasms (Cancer) 01/2023 - 01/2017
13	Melanoma (Melanoma, Malignant) 12/2022 - 11/2017
7	Acidosis 12/2022 - 12/2017
2	Stomach Neoplasms (Stomach Cancer) 01/2023 - 09/2022
2	Neoplasm Metastasis (Metastasis) 12/2022 - 10/2022
2	Chronic Renal Insufficiency 10/2022 - 11/2019
1	Bone Diseases (Bone Disease) 02/2023
1	Bone Resorption 02/2023
1	Osteoporosis 02/2023
1	Adenocarcinoma of Lung 01/2023
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2023
1	Lung Neoplasms (Lung Cancer) 01/2023
1	Inflammation (Inflammations) 12/2022
1	Hypoxia (Hypoxemia) 12/2022
1	Adenocarcinoma 09/2022
1	Idiopathic Pulmonary Fibrosis 05/2022
1	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 05/2022
1	Adenomatous Polyposis Coli (Familial Adenomatous Polyposis) 10/2021
1	Disease Progression 12/2020
1	Colonic Neoplasms (Colon Cancer) 12/2019
1	Colorectal Neoplasms (Colorectal Cancer) 12/2019
1	Breast Neoplasms (Breast Cancer) 12/2019
1	Cardiovascular Diseases (Cardiovascular Disease) 11/2019
1	Diabetes Mellitus 11/2019
1	Noncommunicable Diseases 11/2019
1	Residual Neoplasm 01/2017

Drug/Important Bio-Agent (IBA)

6	Carbonic Anhydrase IXIBA 01/2023 - 12/2017
5	SLC-0111IBA 01/2023 - 12/2017
4	VemurafenibIBA 01/2022 - 11/2017
3	IntegrinsIBA 01/2023 - 01/2019
3	Fluorouracil (Carac)FDA LinkGeneric 01/2023 - 12/2019
3	Urokinase Plasminogen Activator ReceptorsIBA 01/2022 - 01/2019
3	oleuropeinIBA 10/2021 - 12/2018
2	LigandsIBA 02/2023 - 01/2023
2	AntioxidantsIBA 02/2023 - 11/2019
2	nintedanibIBA 01/2023 - 05/2022
2	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2019
2	Oxygen (Dioxygen)IBA 12/2022 - 11/2018
2	AcidsIBA 10/2022 - 10/2020
2	Lactic Acid (Lactate)FDA LinkGeneric 05/2022 - 10/2020
2	olive leaf extractIBA 01/2020 - 12/2018
2	Dacarbazine (DIC)FDA LinkGeneric 12/2019 - 12/2018
2	Everolimus FDA Link 12/2018 - 11/2017
1	Fibroblast Growth Factor-23IBA 02/2023
1	Integrin alpha5beta1IBA 01/2023
1	CytokinesIBA 01/2023
1	Fibronectins (Fibronectin)IBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2023
1	Oxaliplatin (Eloxatin)FDA LinkGeneric 01/2023
1	taxaneIBA 01/2023
1	Docetaxel (Taxotere)FDA Link 01/2023
1	Leucovorin (Folinic Acid)FDA Link 01/2023
1	PlatinumIBA 01/2023
1	Estrogen ReceptorsIBA 12/2022
1	Gonadal Steroid Hormones (Sex Hormones)IBA 12/2022
1	MicroRNAs (MicroRNA)IBA 10/2022
1	Olive OilIBA 10/2022
1	Cisplatin (Platino)FDA LinkGeneric 09/2022
1	oleocanthalIBA 09/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 09/2022
1	Tyrosine Kinase InhibitorsIBA 05/2022
1	Cyclic PeptidesIBA 05/2022
1	Antifibrotic AgentsIBA 05/2022
1	Carbonic Anhydrases (Carbonic Anhydrase)IBA 12/2020
1	Histone Deacetylases (Histone Deacetylase)IBA 12/2020
1	Vorinostat FDA Link 12/2020
1	Conditioned Culture MediaIBA 12/2020
1	Histone Deacetylase InhibitorsIBA 12/2020
1	Cytostatic AgentsIBA 12/2019
1	Complement System Proteins (Complement)IBA 12/2019
1	Temozolomide (Temodar)FDA LinkGeneric 12/2019
1	Drug CombinationsIBA 12/2019
1	Doxorubicin (Adriamycin)FDA LinkGeneric 12/2019
1	Amyloid (Amyloid Fibrils)IBA 11/2019
1	Growth InhibitorsIBA 11/2019
1	Histocompatibility Antigens Class IIBA 08/2019
1	HLA-B Antigens (HLA-B)IBA 08/2019
1	Monoclonal AntibodiesIBA 08/2019
1	EnzymesIBA 08/2019
1	Sepharose (Agarose)IBA 01/2019
1	Peptides (Polypeptides)IBA 01/2019
1	Sunitinib (Sutent)FDA Link 01/2019
1	PolyphenolsIBA 12/2018
1	PlasticsIBA 11/2018

Therapy/Procedure

10	Therapeutics 12/2022 - 01/2017
6	Drug Therapy (Chemotherapy) 12/2022 - 12/2018
1	Radiotherapy 12/2019
1	Aftercare (After-Treatment) 01/2017